Employees: 11 (2023.0)Legal category: 5785Size: PMECreation date: 2020-07-04 (5 years)Status: ActiveBusiness sector: Commerce de détail de produits pharmaceutiques en magasin spécialiséLocation: FORT-DE-FRANCE (97200), Martinique
Les données financières de cette entreprise sont partiellement disponibles (liasse simplifiée ou données confidentielles). Certaines sections ne sont pas affichées.
PHARMACIE NOUVELLE CLAIRIERE : revenue, balance sheet and financial ratios
PHARMACIE NOUVELLE CLAIRIERE is a French company
founded 5 years ago,
specialized in the sector Commerce de détail de produits pharmaceutiques en magasin spécialisé.
Based in FORT-DE-FRANCE (97200),
this company of category PME
shows in 2023 a net income positive of 142 k€.
Find below the complete financial statements, solvency ratios, working capital requirements and sector comparison.
Financial history - PHARMACIE NOUVELLE CLAIRIERE (SIREN 888305448)
Indicator
2023
2021
Revenue
N/C
N/C
Net income
142 452 €
141 596 €
EBITDA
N/C
N/C
Net margin
N/C
N/C
Revenue and income statement
In 2023, PHARMACIE NOUVELLE CLAIRIERE generates positive net income of 142 k€. Net income represents the final profit after all expenses (operating, financial, exceptional) and corporate tax. Change over 2021-2023: 142 k€ -> 142 k€.
Net income (2023)
?
Net income
Definition
Profit or loss after all expenses, including taxes and exceptional items.
Formula
Current income + Exceptional income - Income tax
142 452 €
Loading income statement...
Income statement
Item
Amount
% Revenue
Change
The detailed income statement is not available for this company (simplified accounts or confidential data).
Chart evolution
Show :
Visualization created via numbers.finance Sources : INPI & BCE - Adjustments : Ministry of Economy
Assets
Loading data...
Item
Gross
Deprec.
Net
%
Change
Assets balance sheet data not available for this company
Liabilities
Loading data...
Item
Year
%
Change
Liabilities balance sheet data not available for this company
Solvency and debt ratios
The debt ratio (= Financial debt / Equity x 100) stands at 1004%. Critical situation: debt significantly exceeds equity, severely limiting borrowing capacity and exposing the company to default risk. Financial autonomy (= Equity / Total assets x 100) reaches 8%. Low autonomy: the company heavily depends on external financing (banks, suppliers).
Debt ratio (2023)
?
Debt ratio
Definition
Measures the proportion of debt to equity.
Formula
(Financial debt / Equity) x 100
Interpretation
< 50% : Low 50-100% : Moderate > 100% : High
1003.944%
Financial autonomy (2023)
?
Financial autonomy
Definition
Share of equity in the company's total financing.
Formula
(Equity / Total assets) x 100
Interpretation
> 30% : Good autonomy 20-30% : Average < 20% : Low
7.571%
Asset age ratio (2023)
?
Asset age ratio
Definition
Measures the degree of wear of tangible assets.
Formula
Accumulated depreciation / Gross fixed assets x 100
Solvency indicators evolution PHARMACIE NOUVELLE CLAIRIERE
Visualization created via numbers.finance Sources : INPI & BCE - Adjustments : Ministry of Economy
Indicator
2021
2023
Debt ratio
1091.387
1003.944
Financial autonomy
6.995
7.571
Repayment capacity
None
None
Cash flow / Revenue
None%
None%
Sector positioning
Debt ratio
1003.942023
2021
2023
Q1: 20.09
Med: 66.92
Q3: 169.24
Watch
In 2023, the debt ratio of PHARMACIE NOUVELLE CLAIRIERE (1003.94) ranks in the top 25% of the sector. This ratio measures the weight of debt relative to equity. A high ratio may indicate excessive dependence on external financing.
Financial autonomy
7.57%2023
2021
2023
Q1: 28.72%
Med: 48.51%
Q3: 68.17%
Average
In 2023, the financial autonomy of PHARMACIE NOUVELLE CLAIRIERE (7.6%) ranks below the median of the sector. This ratio represents the share of equity in total financing. An improvement would strengthen the competitive position.
Liquidity ratios
The liquidity ratio (= Current assets / Current liabilities) stands at 84.52. Concretely, the company has €2 of liquid assets for every €1 of short-term debt: no cash risk within 12 months.
Liquidity ratio (2023)
?
Liquidity ratio
Definition
Ability to meet short-term debts with current assets.
Formula
Current assets / Current liabilities
Interpretation
> 1.5 : Very good 1-1.5 : Fair < 1 : Liquidity risk
84.519
Liquidity indicators evolution PHARMACIE NOUVELLE CLAIRIERE
Visualisation créée via abddaf.fr Sources : INPI & BCE - Retraitements : Ministère de l'économie
Indicator
2021
2023
Liquidity ratio
127.331
84.519
Interest coverage
None
None
Sector positioning
Liquidity ratio
84.522023
2021
2023
Q1: 135.23
Med: 189.76
Q3: 270.17
Watch-7 pts over 2 years
In 2023, the liquidity ratio of PHARMACIE NOUVELLE CLAIRIERE (84.52) ranks in the bottom 25% of the sector. This ratio measures the ability to cover short-term debt with current assets. A ratio below 1 may signal potential cash flow tensions.
Positioning of PHARMACIE NOUVELLE CLAIRIERE in its sector
Comparison with sector Commerce de détail de produits pharmaceutiques en magasin spécialisé
Valuation estimate
Based on 220 transactions of similar company sales
in 2023,
the value of PHARMACIE NOUVELLE CLAIRIERE is estimated at
1 680 858 €
(range 1 022 210€ - 2 362 910€).
This multiples method compares the actual sale price of similar companies to their financial indicators (Revenue, EBITDA, Net Income). It provides a market-based indicative estimate.
Estimated enterprise value2023
220 transactions
1022k€1680k€2362k€
1 680 858 €Range: 1 022 210€ - 2 362 910€
NAF 5 année 2023
Valuation method used
Net Income Multiple
142 452 €
×
11.8x
=1 680 859 €
Range: 1 022 211€ - 2 362 911€
Only this financial indicator is available for this company.
Valuation evolution
Visualisation creee via abddaf.fr Sources : BODACC & INPI
How is this estimate calculated?
This estimate is based on the analysis of 220 actual transactions of similar company sales (same NAF code) registered with BODACC between 2016 and 2025.
EBITDA Multiple: Preferred method for profitable SMEs. EBITDA reflects the ability to generate cash.
Revenue Multiple: Used for growing companies or those with low profitability. Reflects commercial potential.
Net Income Multiple: Relevant for mature companies with stable results.
This estimate is provided for information purposes only. A precise valuation requires in-depth analysis (assets, liabilities, prospects, market...).
Similar companies (Commerce de détail de produits pharmaceutiques en magasin spécialisé)
Compare PHARMACIE NOUVELLE CLAIRIERE with other companies in the same sector:
Frequently asked questions about PHARMACIE NOUVELLE CLAIRIERE
What is the revenue of PHARMACIE NOUVELLE CLAIRIERE ?
The revenue of PHARMACIE NOUVELLE CLAIRIERE is not publicly disclosed (confidential accounts filed with INPI).
Is PHARMACIE NOUVELLE CLAIRIERE profitable?
Yes, PHARMACIE NOUVELLE CLAIRIERE generated a net profit of 142 k€ in 2023.
Where is the headquarters of PHARMACIE NOUVELLE CLAIRIERE ?
The headquarters of PHARMACIE NOUVELLE CLAIRIERE is located in FORT-DE-FRANCE (97200), in the department Martinique.
Where to find the tax return of PHARMACIE NOUVELLE CLAIRIERE ?
The tax return of PHARMACIE NOUVELLE CLAIRIERE is available on this page. Click on a year in the 'Data by year' section to view the account details (assets, liabilities, income statement). Data comes from INPI (National Institute of Industrial Property).
In which sector does PHARMACIE NOUVELLE CLAIRIERE operate?
PHARMACIE NOUVELLE CLAIRIERE operates in the sector Commerce de détail de produits pharmaceutiques en magasin spécialisé (NAF code 47.73Z). See the 'Sector positioning' section above to compare the company with its competitors.
Item evolution
Rotate your phone to landscape mode to view the chart